Option Care Health
Track in portfolio
Price chart
Description
Company and Business Model
Option Care Health operates in the healthcare sector, specializing in providing home and alternate site infusion services. Its core offerings include a range of infusion therapies, clinical services, and pharmacy solutions. The company primarily generates revenue through patient care services, focusing on chronic and complex conditions requiring ongoing treatment. Major business segments include home infusion, specialty pharmacy, and clinical management services, catering to a diverse patient population.
Investment Profile
The investment profile of Option Care Health is more aligned with growth investors, given its focus on expanding service offerings and revenue growth. The company demonstrates strong quarterly revenue increases, indicating potential for future performance. It may also appeal to investors seeking a balanced approach, as it operates in a stable sector with ongoing demand for healthcare services.
Fundamental metrics (experimental) Updated: 2026-11-20
- EPS (TTM) — earnings per share for the last 12 months, $
- 1.39
- Revenue QoQ — quarter-over-quarter revenue growth
- 3.5%
- EPS surprise
- 0.1%
- 20d volatility
- 0.5%
| Date | Before | After | Reason |
|---|---|---|---|
| 2026-10-07 | — | Buy | Strong momentum and positive revenue growth signal opportunity. |
| Date | Analyst | Action | Target | Price Then |
|---|---|---|---|---|
| 2026-10-12 | Morgan Stanley | Rating Downgraded | — → 32.05 | 31.07 |
| 2026-10-09 | UBS | Rating Downgraded | — → 32.05 | 31.065 |
| 2026-10-07 | Truist Financial | Rating Downgraded | — → 32.05 | 31 |
| 2026-10-06 | Jefferies | Rating Downgraded | — → 32.05 | 31 |
| 2026-07-30 | Deutsche Bank | Update | — → 24 | 23.93 |
| 2026-07-17 | Stephens | Rating Downgraded | — → 24 | 22.1 |
| 2026-06-08 | Goldman Sachs | Update | — → 22 | 20.51 |
| 2026-05-06 | Morgan Stanley | Target Lowered | 38 → 28 | 21.47 |
| 2026-05-01 | Truist Financial | Target Lowered | 40 → 30 | 20.02 |
| 2026-05-01 | Barrington | Target Lowered | 42 → 32 | 20.025 |
| 2026-05-01 | UBS | Target Lowered | 45 → 39 | 20.053 |
| 2026-05-01 | Stephens | Target Lowered | 40 → 30 | 20.15 |
| 2026-05-01 | Deutsche Bank | Target Lowered | 38 → 26 | 20.33 |